Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 30.72x is in line with its 5-year average of 28.90x, around the middle of its 5-year range (-99.42x–92.70x).
13.23% below its 12-month average of 35.40x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2026 (2026-03-31): 92.70x.
INTEREST COVERAGE RATIO
30.72x
INTEREST COVERAGE RATIO AVG TTM
35.40x
INTEREST COVERAGE RATIO AVG 3Y
28.03x
INTEREST COVERAGE RATIO AVG 5Y
28.90x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-13.23%
CURRENT VS 3Y AVG
+9.60%
CURRENT VS 5Y AVG
+6.31%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.85x
median of 383 covered companies
CURRENT VS SECTOR MEDIAN
+733.40%
vs the sector median at left
Healthcare Services Group, Inc.
Market Cap
$1.46B
Interest Coverage Ratio
30.72x
TTM Avg
35.40x
3Y Avg
28.03x
5Y Avg
28.90x
Market Cap
$1.44B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.47B
Interest Coverage Ratio
-131.05x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.49B
Interest Coverage Ratio
1.06x
TTM Avg
1.06x
3Y Avg
1.45x
5Y Avg
1.23x
Market Cap
$1.43B
Interest Coverage Ratio
0.60x
TTM Avg
0.60x
3Y Avg
0.60x
5Y Avg
0.60x
Market Cap
$1.43B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.50B
Interest Coverage Ratio
0.02x
TTM Avg
0.02x
3Y Avg
0.02x
5Y Avg
0.02x
Market Cap
$1.53B
Interest Coverage Ratio
12.40x
TTM Avg
9.47x
3Y Avg
9.47x
5Y Avg
17.56x
Market Cap
$1.38B
Interest Coverage Ratio
-11.07x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Healthcare Services Group, Inc. (HCSG) | $1.46B | 30.72x | 35.40x | 28.03x | 28.90x |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.44B | N/A | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.47B | -131.05x | N/A | N/A | N/A |
| Certara, Inc. (CERT)vs › | $1.49B | 1.06x | 1.06x | 1.45x | 1.23x |
| AnaptysBio, Inc. (ANAB)vs › | $1.43B | 0.60x | 0.60x | 0.60x | 0.60x |
| Braveheart Bio, Inc. (BRVE)vs › | $1.43B | N/A | N/A | N/A | N/A |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.50B | 0.02x | 0.02x | 0.02x | 0.02x |
| Nutex Health, Inc. (NUTX)vs › | $1.53B | 12.40x | 9.47x | 9.47x | 17.56x |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.38B | -11.07x | N/A | N/A | N/A |
| Innoviva, Inc. (INVA)vs › | $1.53B | 9.81x | 8.66x | 9.09x | 12.26x |
Interest Coverage
30.7x
Debt/Equity
0.03
Current Ratio
3.02
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | 92.70x |
| 2025-12-31 | 68.22x |
| 2025-09-30 | 60.99x |
| 2025-06-30 | -99.42x |
| 2025-03-31 | 54.53x |
| 2024-12-31 | 12.10x |
| 2024-09-30 | 12.24x |
| 2024-06-30 | -0.96x |
| 2024-03-31 | 10.88x |
| 2023-12-31 | 15.19x |
| 2023-09-30 | -2.45x |
| 2023-06-30 | 5.17x |
| 2023-03-31 | 7.74x |
| 2022-12-31 | 16.06x |
| 2022-09-30 | 0.79x |
| 2022-06-30 | 22.08x |
| 2022-03-31 | 27.56x |
| 2021-12-31 | 4.38x |
| 2021-09-30 | 35.78x |
| 2021-06-30 | 44.29x |
| 2021-03-31 | 90.63x |
| 2020-12-31 | 109.76x |
| 2020-09-30 | 115.85x |
| 2020-06-30 | 77.73x |
| 2020-03-31 | 71.24x |
| 2019-12-31 | 26.60x |
| 2019-09-30 | 32.06x |
| 2019-06-30 | 29.38x |
| 2019-03-31 | 7.33x |
| 2018-09-30 | 39.58x |
| 2018-06-30 | 45.00x |
| 2018-03-31 | -2.58x |
